Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Dealmaking Pays Off For Allergan As Revenue Rises 124% In 2015

This article was originally published in Scrip

Executive Summary

Allergan PLC's dealmaking ways paid off in 2015 as revenue rose 124% to $15.1bn and non-GAAP earnings per share grew 78% to $13.43, thanks in large part to Actavis PLC's $66bn acquisition of Botox (onabotulinumtoxinA) maker Allergan Inc. last year and other recent transactions.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register